Fierce Pharma June 24, 2024
After losing round one of its respiratory syncytial virus (RSV) vaccine bout with GSK, Pfizer is rallying. And what better way to do it than to win a major contract in your rival’s home country?
The U.K. government has selected Pfizer to supply 5 million doses of its RSV shot Abrysvo over the next two years. The notice was posted earlier this month on the U.K. government’s “Find a Tender” website, with the contract value withheld “so as not to prejudice the legitimate commercial interest of the supplier,” it explained.
On Monday morning, the U.K. introduced its RSV immunization program, with instructions on how patients can receive their shots of Abrysvo. The vaccine is expected to become available in early...
Today's Sponsors
Today's Sponsor